脑机接口，大消息！

Core Insights - Neuralink, a brain-machine interface company founded by Elon Musk, has showcased its latest research achievements and product development direction [1] Group 1: Clinical Trials and Patient Outcomes - Neuralink has implanted its N1 brain-machine interface in 7 patients, including 4 with spinal cord injuries and 3 with amyotrophic lateral sclerosis (ALS), enabling them to control computers using their thoughts [2] - One patient successfully controlled a cursor and performed tasks such as typing, browsing the web, managing emails, and playing games through the brain-machine interface [2] - Another patient utilized the brain-machine interface for professional work, including using CAD software for design tasks [2] Group 2: Funding and Financial Developments - In June, Neuralink completed a $650 million Series E funding round, with major investors including Ark Invest, DFJ Growth, Founders Fund, Lightspeed Venture Partners, Sequoia Capital, and Xingsheng Capital [2] - The funding aims to accelerate the dissemination of brain-machine interface technology to patients and promote future device innovations [2] Group 3: Market Potential and Growth Projections - The global brain-machine interface market is projected to reach $1.98 billion in 2023 and exceed $6 billion by 2028, with a compound annual growth rate (CAGR) of 25.22% [3] - In China, the brain-machine interface market is currently around 1 billion yuan, accounting for less than 10% of the global market share, but is expected to exceed 120 billion yuan by 2040, with an annual CAGR of approximately 26% [3] - Non-invasive brain-machine interfaces dominate the market, holding an 86% share, while invasive interfaces present significant potential due to high barriers to entry [3] Group 4: Regulatory and Policy Support - Recent policies in China are expected to accelerate the development of the brain-machine interface industry, including the establishment of national standards for non-invasive medical devices using brain-machine interface technology [4] - The National Medical Products Administration has proposed measures to optimize the regulatory process for high-end medical devices, including those based on brain-machine interface technology [5] - Action plans from Beijing and Shanghai aim to cultivate influential tech companies and promote the commercialization of brain-machine interface products across various sectors by 2030 [6]